These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34534173)

  • 1. New insights into the microbiome in kidney transplantation.
    Kim JS; Sze C; Barbar T; Lee JR
    Curr Opin Organ Transplant; 2021 Dec; 26(6):582-586. PubMed ID: 34534173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients.
    Zegarska J; Hryniewiecka E; Żochowska D; Tszyrsznic W; Jaźwiec R; Borowiec A; Pawłowska E; Dadlez M; Pączek L
    Ann Transplant; 2015 Aug; 20():483-92. PubMed ID: 26313036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gut microbiota on kidney transplantation.
    Winichakoon P; Chaiwarith R; Chattipakorn N; Chattipakorn SC
    Transplant Rev (Orlando); 2022 Jan; 36(1):100668. PubMed ID: 34688985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important lack of difference in tacrolimus and mycophenolic acid pharmacokinetics between Aboriginal and Caucasian kidney transplant recipients.
    Barraclough KA; Metz D; Staatz CE; Gorham G; Carroll R; Majoni SW; Cherian S; Swaminathan R; Holford N
    Nephrology (Carlton); 2022 Sep; 27(9):771-779. PubMed ID: 35727904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study.
    Lee JR; Huang J; Magruder M; Zhang LT; Gong C; Sholi AN; Albakry S; Edusei E; Muthukumar T; Lubetzky M; Dadhania DM; Taur Y; Pamer EG; Suthanthiran M
    Transpl Infect Dis; 2019 Dec; 21(6):e13180. PubMed ID: 31544324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of the Gut Microbiota on Transplanted Kidney Function.
    Przybyciński J; Drożdżal S; Wilk A; Dziedziejko V; Szumilas K; Pawlik A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
    J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urinary microbiome shows different bacterial genera in renal transplant recipients and non-transplant patients at time of acute kidney injury - a pilot study.
    Gerges-Knafl D; Pichler P; Zimprich A; Hotzy C; Barousch W; Lang RM; Lobmeyr E; Baumgartner-Parzer S; Wagner L; Winnicki W
    BMC Nephrol; 2020 Apr; 21(1):117. PubMed ID: 32252662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.
    Prasad N; Gupta P; Jain M; Bhadauria D; Gupta A; Sharma RK; Kaul A
    Exp Clin Transplant; 2013 Jun; 11(3):215-21. PubMed ID: 23767942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Everolimus Plus Standard-Dose Tacrolimus Immunosuppression in De Novo Kidney Transplant: A Retrospective, Single-Center Study of 225 Transplants.
    Okabe Y; Noguchi H; Sato Y; Mei T; Kaku K; Ueki K; Tsuchimoto A; Nakamura M
    Exp Clin Transplant; 2022 Mar; 20(4):362-369. PubMed ID: 35475420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplant associated infections-The role of the gastrointestinal microbiota and potential therapeutic options.
    Chan S; Hawley CM; Campbell KL; Morrison M; Campbell SB; Isbel NM; Francis RS; Playford EG; Johnson DW
    Nephrology (Carlton); 2020 Jan; 25(1):5-13. PubMed ID: 31587409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
    Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients.
    Rong Y; Colbourne P; Gourishankar S; Kiang TKL
    Clin Drug Investig; 2022 Mar; 42(3):207-219. PubMed ID: 35182318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.
    Gatault P; Kamar N; Büchler M; Colosio C; Bertrand D; Durrbach A; Albano L; Rivalan J; Le Meur Y; Essig M; Bouvier N; Legendre C; Moulin B; Heng AE; Weestel PF; Sayegh J; Charpentier B; Rostaing L; Thervet E; Lebranchu Y
    Am J Transplant; 2017 May; 17(5):1370-1379. PubMed ID: 27862923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and tacrolimus dosing in kidney transplantation.
    Lee JR; Muthukumar T; Dadhania D; Taur Y; Jenq RR; Toussaint NC; Ling L; Pamer E; Suthanthiran M
    PLoS One; 2015; 10(3):e0122399. PubMed ID: 25815766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on BK virus associated nephropathy related risk factors in renal transplant recipients].
    Huang G; Wang C; Luo X; Huang Y; Fei J; Deng S; Li J; Chen G; Fu Q; Deng R; Qiu J; Chen L
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(38):3124-7. PubMed ID: 26814103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients.
    Dugast E; Soulillou JP; Foucher Y; Papuchon E; Guerif P; Paul C; Riochet D; Chesneau M; Cesbron A; Renaudin K; Dantal J; Giral M; Brouard S
    Am J Transplant; 2016 Nov; 16(11):3255-3261. PubMed ID: 27367750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects].
    Guirong YE; Minjie Z; Lixin YU; Junsheng YE; Lin Y; Lisha S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1401-1408. PubMed ID: 30613005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.